CROWLEY Richard 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Nov 22, 2011
Insider Transaction Report
Form 4
CROWLEY Richard
EVP Biopharmaceutical Operatio
Transactions
- Purchase
Common Stock, $.01 par value per share
2011-11-21$2.53/sh+3,000$7,590→ 103,000 total